Assignee
BERNETT MATTHEW J
US·5 granted patents·6 pending applications·141 citations·filing 2007–2013
Top patents by PatentIndex Score
11 records- 0196US8551485B2Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cellsBERNETT MATTHEW J·Filed 2009·Granted Oct 8, 2013·45 cites·27 claims
- 0296US8524867B2Optimized antibodies that target CD19BERNETT MATTHEW J·Filed 2007·Granted Sep 3, 2013·56 cites·32 claims
- 0395US8314213B2Human equivalent monoclonal antibodies engineered from nonhuman variable regionsBERNETT MATTHEW J·Filed 2009·Granted Nov 20, 2012·36 cites·4 claims
- 0480US8394374B2Optimized antibodies that target HM1.24BERNETT MATTHEW J·Filed 2007·Granted Mar 12, 2013·4 cites·11 claims
- 0558US2012082664A1Optimized antibodies that target cd19BERNETT MATTHEW J·Filed 2011·Application pending·0 cites
- 0655US9040042B2Optimized antibodies that target HM1.24BERNETT MATTHEW J·Filed 2013·Granted May 26, 2015·0 cites·20 claims
- 0750US2009162382A1Optimized ca9 antibodies and methods of using the sameBERNETT MATTHEW J·Filed 2008·Application pending·0 cites
- 0849US2008199471A1Optimized cd40 antibodies and methods of using the sameBERNETT MATTHEW J·Filed 2008·Application pending·0 cites
- 0949US2008254027A1Optimized CD5 antibodies and methods of using the sameBERNETT MATTHEW J·Filed 2007·Application pending·0 cites
- 1048US2008219974A1Optimized antibodies that target hm1.24BERNETT MATTHEW J·Filed 2007·Application pending·0 cites
- 1148US2008260731A1Optimized antibodies that target cd19BERNETT MATTHEW J·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →